Poniard Pharmaceuticals (PARD) Inactive 10-Q2011 Q1 Quarterly report

Content analysis

Filed: 13 May 11, 12:00am

Date: May 13, 2011

/s/ RONALD A. MARTELL

Ronald A. Martell

Chief Executive Officer

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: advisory, afforded, automatically, Avenue, Biotech, budget, certainty, chemotherapeutic, complexity, desired, discharged, dissolution, doubt, efficient, Elliott, entry, exact, extent, extinguishment, extremely, failure, firm, forecast, GAAP, half, highly, history, improved, independent, indirect, intention, interdealer, larger, latitude, lead, Link, metastatic, mitigate, nature, notice, notifying, occupy, outcome, page, payoff, penalty, preceding, preserve, profile, progressed, proportion, ratio, resistant, retain, reverse, safety, satisfaction, select, show, size, split, standard, successfully, suggest, uncertainty, unpaid, vacation, varied, voluntarily, Washington, West

Removed: acceptable, account, achieved, acquire, agency, allocable, allocating, anytime, attractive, avoid, Azimuth, banker, beneficially, borrow, closure, commercially, complying, conform, conjunction, consent, constituting, contractual, create, default, dependent, directed, discontinue, distressed, earn, employment, end, entering, equivalent, establishing, establishment, exercisable, extended, federal, file, foreign, foreseeable, funding, government, identification, inaccuracy, initiative, insolvency, joint, lab, lesser, long, Lynch, marketing, Merrill, modification, modify, multiple, nonpayment, ongoing, Opportunity, partially, partner, performing, permitting, predictable, receipt, reclassified, recognition, refocused, registrational, reimbursement, relationship, release, renegotiate, repurchase, reputation, requiring, residual, restatement, revenue, scope, separate, separately, shown, source, subleasing, suffered, sustain, treated, unrestricted, waive

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PARD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF QUARTERLY REPORT

I, Ronald A. Martell, Chief Executive Officer of Poniard Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350, that:

the Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

the information contained in the Report 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.